A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction

Listeria monocytogenes (Lm)-based vaccines stimulate both innate and adaptive immunity. ANZ-100 is a live-attenuated Lm strain (Lm ΔactA/ΔinlB). Uptake by phagocytes in the liver results in local inflammatory responses and activation and recruitment of natural killer (NK) and T cells, in association...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Clinical cancer research Ročník 18; číslo 3; s. 858
Hlavní autori:	Le, Dung T, Brockstedt, Dirk G, Nir-Paz, Ran, Hampl, Johannes, Mathur, Shruti, Nemunaitis, John, Sterman, Daniel H, Hassan, Raffit, Lutz, Eric, Moyer, Bentley, Giedlin, Martin, Louis, Jana-Lynn, Sugar, Elizabeth A, Pons, Alice, Cox, Andrea L, Levine, Jordana, Murphy, Aimee Luck, Illei, Peter, Dubensky, Jr, Thomas W, Eiden, Joseph E, Jaffee, Elizabeth M, Laheru, Daniel A
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.02.2012
Predmet:	Adult Aged Bacterial Vaccines - administration & dosage Bacterial Vaccines - adverse effects Bacterial Vaccines - immunology Cancer Vaccines - administration & dosage Cancer Vaccines - adverse effects Cancer Vaccines - immunology Carcinoma - secondary Carcinoma - therapy Cytokines - blood Female Flow Cytometry GPI-Linked Proteins - immunology Humans Immunohistochemistry Listeria monocytogenes - immunology Liver Neoplasms - immunology Liver Neoplasms - secondary Liver Neoplasms - therapy Lung Neoplasms - pathology Lung Neoplasms - therapy Lymphocyte Activation - immunology Lymphocyte Count Male Maximum Tolerated Dose Mesothelin Mesothelioma - pathology Mesothelioma - therapy Middle Aged Ovarian Neoplasms - pathology Ovarian Neoplasms - therapy Pancreatic Neoplasms - pathology Pancreatic Neoplasms - therapy Vaccines, Attenuated - administration & dosage Vaccines, Attenuated - adverse effects Vaccines, Attenuated - immunology
ISSN:	1557-3265, 1557-3265
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!